Rituximab is used primarily and routinely to treat blood related cancers, namely lymphoma.
Just by chance, 3 Norwegian doctors discovered it really helped a patient with Chronic Fatigue Syndrome (CFS). It is now used off-label for that purpose and to treat other autoimmune diseases such as multiple sclerosis and systemic lupus erythematosus. It is also effective against rheumatoid arthritis.
I suffer from CFS. One of the symptoms I share with Zobra's young Sumac Syndrome is a low blood volume. Our blood count is OK, it's just that there is not enough blood flowing. Thus, I am not surprised that Rituximab has positive effects on Sumac Syndrome.
I have not had access to Rituximab myself, as its use to treat CFS is still ongoing trials.
I feel, however, that this "biological" type of chemotherapy medication has been around for a long time and can't be that expensive. Created in 1986, it was FDA approved for use in 1992. The cost of research has certainly been capitalized by now and the product itself can't be that costly to manufacture.
I don't know if I'm allowed to say where I live but I will point out that I know of people suffering from arthritis who have been receiving their injections at their local hospitals for many years, and for free!! They are able to work and pay taxes!
I can't understand that Rituxan is refused a person who will, in all probability, lose sight and hearing without it. It is extremely cold-hearted,
from a human point of view, but it is a unenlightened decision from a social perspective. As societies, we thrive, in so many ways, to keep our people active and productive, for the benefit of all. I don't see the economy in condemning a youngster to grow in an adulthood where he will have to call on so many social services to lead a normal life.
I'm sorry Zobra, that I could not find any safe place to recommend to purchase rituximab at an affordable price.
Godspeed.